ESOC 2024 | Improving outcome measures for assessing stroke recovery

Terence Quinn, MD, MRCP, MBCHB (hons), University of Glasgow, Glasgow, UK, emphasizes the importance of selecting appropriate outcome measures to assess stroke recovery in clinical trials. While traditional measures like the modified Rankin Scale are widely used, they may not capture subtle changes or address cognitive and mood issues that stroke survivors often find most impactful. Dr. Quinn advocates for the development of robust, standardized measures to better evaluate interventions targeting these aspects. This interview took place at the 10th European Stroke Organisation Conference (ESOC) 2024 in Basel, Switzerland.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.